News

A bioluminescent indicator glows when a cancer drug is active inside the brain, identifying which medications cross the blood-brain barrier.

The collaboration will enable the development of medications to treat a type of brain cancer.

Stanford Medicine researchers develop a first-of-its-kind wireless device that uses light-activated nanoparticles to kill cancer cells.

the Stanford-NBTS Brain Tumor Symposium convened together scientists and leaders from across Stanford and the National Brain Tumor Society to discuss innovative approaches to studying and treating brain tumors.

A preschooler's brain tumor is revealed after he hits his head at a T-ball game, allowing doctors to remove it before it caused any issues.